Budget impact analysis of PCSK9 inhibitors costs from a community payers’ perspective in Apulia, Italy

INTRODUCTION: Despite established clinical efficacy of PCSK9 inhibitors (PCSK9i) in reducing cardiovascular events, their cost still represents a big matter of debate. We therefore sought to estimate possible impact of PCSK9i therapy from a community taxpayers’ perspective with a budget impact analy...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Open Heart
Autori principali: Brunetti, Natale Daniele, De Gennaro, Luisa, Tricarico, Lucia, Caldarola, Pasquale
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2019
Soggetti:
Health Care Delivery, Economics and Global Health Care
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6667935/
https://ncbi.nlm.nih.gov/pubmed/31413843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/openhrt-2019-001018
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi